153 related articles for article (PubMed ID: 9329973)
1. A synthetic peptide derived from the sequence of a type I collagen receptor inhibits type I collagen-mediated platelet aggregation.
Chiang TM; Kang AH
J Clin Invest; 1997 Oct; 100(8):2079-84. PubMed ID: 9329973
[TBL] [Abstract][Full Text] [Related]
2. Adhesive domains in the collagen III fragment alpha1(III)CB4 that support alpha2beta1- and von Willebrand factor-mediated platelet adhesion under flow conditions.
Verkleij MW; IJsseldijk MJ; Heijnen-Snyder GJ; Huizinga EG; Morton LF; Knight CG; Sixma JJ; de Groot PG; Barnes MJ
Thromb Haemost; 1999 Sep; 82(3):1137-44. PubMed ID: 10494778
[TBL] [Abstract][Full Text] [Related]
3. Cloning, characterization, and functional studies of a nonintegrin platelet receptor for type I collagen.
Chiang TM; Rinaldy A; Kang AH
J Clin Invest; 1997 Aug; 100(3):514-21. PubMed ID: 9239397
[TBL] [Abstract][Full Text] [Related]
4. Type I and type III collagen-platelet interaction: inhibition by type specific receptor peptides.
Zhu J; Cole F; Woo-Rasberry V; Fang XR; Chiang TM
Thromb Res; 2007; 119(1):111-9. PubMed ID: 16472843
[TBL] [Abstract][Full Text] [Related]
5. A recombinant protein and a chemically synthesized peptide containing the active peptides of the platelet collagen receptors inhibit ferric chloride-induced thrombosis in a rat model.
Du H; Zawaski JA; Gaber MW; Chiang TM
Thromb Res; 2007; 121(3):419-26. PubMed ID: 17544485
[TBL] [Abstract][Full Text] [Related]
6. Platelet-collagen interaction. Inhibition by a monoclonal antibody raised against collagen receptor.
Chiang TM; Jin A; Kang AH
J Immunol; 1987 Aug; 139(3):887-92. PubMed ID: 3598192
[TBL] [Abstract][Full Text] [Related]
7. A synthetic nonapeptide derived from the sequence of a platelet type I collagen receptor inhibits type I collagen-mediated platelet aggregation.
Chiang TM
Am J Med Sci; 2000 Dec; 320(6):362-7. PubMed ID: 11149547
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody to platelet type III collagen-binding protein (TIIICBP) binds to blood and vascular cells, and inhibits platelet vessel-wall interactions.
Monnet E; Depraetere H; Legrand C; Deckmyn H; Fauvel-Lafève F
Thromb Haemost; 2001 Aug; 86(2):694-701. PubMed ID: 11522024
[TBL] [Abstract][Full Text] [Related]
9. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain.
Zhou Q; Dangelmaier C; Smith JB
Biochem Biophys Res Commun; 1996 Feb; 219(3):720-6. PubMed ID: 8645248
[TBL] [Abstract][Full Text] [Related]
10. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
Chiang TM; Zhu J
Thromb Res; 2005; 115(6):503-8. PubMed ID: 15792682
[TBL] [Abstract][Full Text] [Related]
11. An all-D amino acid peptide model of alpha1(IV)531-543 from type IV collagen binds the alpha3beta1 integrin and mediates tumor cell adhesion, spreading, and motility.
Li C; McCarthy JB; Furcht LT; Fields GB
Biochemistry; 1997 Dec; 36(49):15404-10. PubMed ID: 9398270
[TBL] [Abstract][Full Text] [Related]
12. The integrin alpha 2 beta 1 (GPIa/IIa)-I-domain inhibits platelet-collagen interaction.
Depraetere H; Wille C; Gansemans Y; Stanssens P; Lauwereys M; Baruch D; De Reys S; Deckmyn H
Thromb Haemost; 1997 May; 77(5):981-5. PubMed ID: 9184414
[TBL] [Abstract][Full Text] [Related]
13. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
[TBL] [Abstract][Full Text] [Related]
14. Involvement of activated integrin alpha2beta1 in the firm adhesion of platelets onto a surface of immobilized collagen under flow conditions.
Moroi M; Onitsuka I; Imaizumi T; Jung SM
Thromb Haemost; 2000 May; 83(5):769-76. PubMed ID: 10823276
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies identify residues 199-216 of the integrin alpha2 vWFA domain as a functionally important region within alpha2beta1.
Tuckwell DS; Smith L; Korda M; Askari JA; Santoso S; Barnes MJ; Farndale RW; Humphries MJ
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):485-93. PubMed ID: 10947963
[TBL] [Abstract][Full Text] [Related]
16. The collagenous domain of class A scavenger receptors is involved in macrophage adhesion to collagens.
Gowen BB; Borg TK; Ghaffar A; Mayer EP
J Leukoc Biol; 2001 Apr; 69(4):575-82. PubMed ID: 11310843
[TBL] [Abstract][Full Text] [Related]
17. Rhodocetin, a novel platelet aggregation inhibitor from the venom of Calloselasma rhodostoma (Malayan pit viper): synergistic and noncovalent interaction between its subunits.
Wang R; Kini RM; Chung MC
Biochemistry; 1999 Jun; 38(23):7584-93. PubMed ID: 10360956
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens.
Jarvis GE; Atkinson BT; Snell DC; Watson SP
Br J Pharmacol; 2002 Sep; 137(1):107-17. PubMed ID: 12183336
[TBL] [Abstract][Full Text] [Related]
19. Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion.
Babinska A; Kedees MH; Athar H; Sobocki T; Sobocka MB; Ahmed T; Ehrlich YH; Hussain MM; Kornecki E
Thromb Haemost; 2002 Apr; 87(4):712-21. PubMed ID: 12008956
[TBL] [Abstract][Full Text] [Related]
20. Binding of collagen alpha1 chains to human platelets.
Chiang TM; Beachey EH; Kang AH
J Clin Invest; 1977 Mar; 59(3):405-11. PubMed ID: 838857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
